+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Forecast 2024-2030- Product Image
Global Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Forecast 2024-2030- Product Image
Sale

Global Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887695
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Central Lab Market size was estimated at USD 3.11 billion in 2023, USD 3.38 billion in 2024, and is expected to grow at a CAGR of 9.25% to reach USD 5.78 billion by 2030.

A central lab operates as a core facility providing high-quality and standardized testing services across various clinical trial sites globally. These labs are pivotal for ensuring data integrity, consistency, and reliability, a prerequisite for effective clinical research and development. The increasing need for specialized testing services, the surge in clinical trials worldwide, and the pharmaceutical industry's emphasis on outsourcing to enhance efficiency and focus on core competencies are expanding the need for central labs. However, the sector faces restraints such as high operational costs, regulatory complexities, and the challenge of maintaining standardization across global operations.

Central labs leverage technological advancements, establish strategic partnerships, and enhance their geographical presence to provide localized services while maintaining international standards to address these restraints. The expansion of biomarker services, personalized medicine, and the integration of artificial intelligence for predictive analysis are setting a trajectory for central labs in the evolving clinical research landscape.

Regional Insights

In the Americas, the central lab market demonstrates robust growth, fueled by a surge in clinical trial activities and a robust infrastructure for research and development. The rising importance of advanced diagnostics and biomarker development has accelerated the investment for central labs in the Americas. The APAC region stands out for its rapid expansion, driven by increasing investments in healthcare, a growing focus on regulatory compliance, and strategic global partnerships facilitating technology transfer and capability enhancements.

A shift toward precision medicine lays the foundation for a dynamic and interconnected global central lab ecosystem for APAC. EMEA showcases an advanced market with stringent regulatory frameworks and a high degree of harmonization in laboratory practices. This region benefits from a history of pharmaceutical research, a highly skilled workforce, and a focus on innovation, particularly in personalized medicine.

Market Trends by Segment

  • Services Type: Preference for central labs for long-term storage of biological samples under controlled conditions for specific management
  • Phase: Integral role of the central labs for the execution of the entire clinical trial process
  • End-use: Need to facilitate seamless clinical trials, ensuring data integrity and operational excellence for pharmaceutical companies
  • Therapeutic Area: Comprehensive diagnostic and prognostic testing for oncology and infectious diseases therapeutic areas

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Medpace Central Labs Expand Singapore Facility

Medpace Central Laboratories expanded its Singapore facility to enhance service delivery to its sponsors. It was established as a primary lab for clinical research within the Asia-Pacific in 2009 and has been operating diligently out of Singapore since 2014. The fully-owned Singapore lab and other Medpace laboratories ensure consistent results by adhering to global operating procedures and leveraging a unified laboratory information management system. The facility is equipped to support various therapeutic areas with advanced testing capabilities.

Vial Announces Collaborative Alliance with MLM Medical Labs for offering Central Laboratory Solutions

Vial joined forces with MLM Medical Labs to enhance its central laboratory offerings by incorporating MLM’s comprehensive solutions, such as study setup management, sample analysis, and its unique MLM Kit building system, which streamlines sample collection through tailor-made kits, barcode tracking, and color-coded labels. Additionally, MLM enhances sample management and clinical data access through its proprietary MLM Sample Storage System and MLM-Online, while its collaboration with TruLab, Inc. ensures meticulous sample tracking and protocol adherence, enriching the clinical trial process for sponsors, CROs, and on-site staff.

Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research to Expand Bioanalytical Capabilities and Shorten Time-to-Deploy Complex Clinical Trials

Cerba HealthCare acquired CIRION BIOPHARMA RESEARCH INC to enhance its HealthCare's offerings under the Cerba Research brand in clinical and IVD trials across a wide range of medical fields. CIRION excels in developing biosimilars/biologics and offers specialized services such as PKPD and immunogenicity testing.

Key Company Profiles

The report delves into recent significant developments in the Central Lab Market, highlighting leading vendors and their innovative profiles. These include ACM Medical Laboratory, Inc., Almac Group, Cerba HealthCare, CROMSOURCE by ClinChoice, Cryoport, Inc., Eurofins Scientific SE, Exagen Inc., Frontage Laboratories, Inc., GBA Group, GCCL Co., Ltd., ICON PLC, InterlabCorp, Intertek Group PLC, IQVIA Inc., LabConnect, Inc., Laboratory Corporation of America Holdings, Lambda Therapeutic Research Ltd., Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd., MDS Pharma Services, Medicover AB, Medpace, Inc., MLM Medical Labs GmbH, Novotech Health Holdings, Pace Analytical Services, LLC, Precision Medicine Group, LLC, Quest Diagnostics Incorporated, REPROCELL Inc., SGS S.A., Shanghai Clinical Research Center, SMS Pharmaceuticals Ltd., Sonic Healthcare International, Syngene International Limited, Thermo Fisher Scientific Inc., Unilabs AB, Versiti, Inc., and WuXi AppTec.

This research report offers invaluable insights into various crucial aspects of the Central Lab Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the number of clinical trials and complexity of drug development activities
5.1.1.2. Government initiatives promoting precision medicine worldwide
5.1.2. Restraints
5.1.2.1. High cost of set-up and maintenance of central labs
5.1.3. Opportunities
5.1.3.1. Technological integrations and smart features in central labs
5.1.3.2. Investments for establishment and expansion of central labs
5.1.4. Challenges
5.1.4.1. Operational limitations and standardization complexities
5.2. Market Segmentation Analysis
5.2.1. Services Type: Preference for central labs for long-term storage of biological samples under controlled conditions for specific management
5.2.2. Phase: Integral role of the central labs for the execution of the entire clinical trial process
5.2.3. End-use: Need to facilitate seamless clinical trials, ensuring data integrity and operational excellence for pharmaceutical companies
5.2.4. Therapeutic Area: Comprehensive diagnostic and prognostic testing for oncology and infectious diseases therapeutic areas
5.3. Market Trend Analysis
5.3.1. Leveraging advanced integration of data analytics for enhanced central lab efficiency across Americas
5.3.2. Significant surge in clinical trials and burgeoning government initiatives for investments and expansions of central lab services across APAC
5.3.3. Stringent regulations concerning biological sample collection for clinical trials and exploration of strategic collaborations between medical laboratories in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Central Lab Market, by Service Type
6.1. Introduction
6.2. Anatomic Pathology/Histology
6.3. Biomarker Services
6.4. Genetic Services
6.5. Microbiology Services
6.6. Special Chemistry Services
6.7. Specimen Management & Storage
7. Central Lab Market, by Phase
7.1. Introduction
7.2. Phase 1
7.3. Phase 2
7.4. Phase 3
8. Central Lab Market, by Therapeutic Area
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cardiovascular Diseases
8.4. Infectious Diseases
8.5. Neurology
8.6. Oncology
9. Central Lab Market, by End-use
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology Companies
9.4. Pathology & Diagnostic Lab
9.5. Pharmaceutical Companies
10. Americas Central Lab Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Central Lab Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Central Lab Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Medpace Central Labs Expand Singapore Facility
13.3.2. Vial Announces Collaborative Alliance with MLM Medical Labs for offering Central Laboratory Solutions
13.3.3. Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research to Expand Bioanalytical Capabilities and Shorten Time-to-Deploy Complex Clinical Trials
13.3.4. Cleveland Clinic and LabConnect announce Strategic Alliance for Improved Patient Care
13.3.5. Versiti Acquires Indiana-based Quantigen for Accelerating Pace of Innovation for Preclinical Research Services
13.3.6. Labor Dr. Wisplinghoff and Labconnect Announce Strategic Alliance - Expanding Global Central Laboratory Services to Accelerate the Development of Medicines
13.3.7. IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
13.3.8. Cerba Research Offers a Customized, Innovative Approach to its Partners in the Laboratory Services
13.3.9. Medpace Central Labs Expand Histology & Anatomic Pathology Services
13.3.10. Thermo Fisher to invest USD 59 Million for Clinical Research Lab Expansion in the U.S.
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CENTRAL LAB MARKET RESEARCH PROCESS
FIGURE 2. CENTRAL LAB MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CENTRAL LAB MARKET DYNAMICS
FIGURE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CENTRAL LAB MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CENTRAL LAB MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CENTRAL LAB MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CENTRAL LAB MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY ANATOMIC PATHOLOGY/HISTOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY ANATOMIC PATHOLOGY/HISTOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOMARKER SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOMARKER SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY GENETIC SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CENTRAL LAB MARKET SIZE, BY GENETIC SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CENTRAL LAB MARKET SIZE, BY MICROBIOLOGY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CENTRAL LAB MARKET SIZE, BY MICROBIOLOGY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIAL CHEMISTRY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIAL CHEMISTRY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIMEN MANAGEMENT & STORAGE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIMEN MANAGEMENT & STORAGE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 1, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 1, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 2, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 2, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 3, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 3, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CENTRAL LAB MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CENTRAL LAB MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CENTRAL LAB MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CENTRAL LAB MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CENTRAL LAB MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CENTRAL LAB MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CENTRAL LAB MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CENTRAL LAB MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CENTRAL LAB MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CENTRAL LAB MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CENTRAL LAB MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CENTRAL LAB MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CENTRAL LAB MARKET SIZE, BY PATHOLOGY & DIAGNOSTIC LAB, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CENTRAL LAB MARKET SIZE, BY PATHOLOGY & DIAGNOSTIC LAB, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CENTRAL LAB MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CENTRAL LAB MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 77. CANADA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 78. CANADA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 79. CANADA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 80. CANADA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 81. CANADA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 82. CANADA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 83. CANADA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 84. CANADA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 85. MEXICO CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 86. MEXICO CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 87. MEXICO CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 88. MEXICO CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 89. MEXICO CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 90. MEXICO CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 91. MEXICO CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 92. MEXICO CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 119. AUSTRALIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 120. AUSTRALIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 121. CHINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 122. CHINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 123. CHINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 124. CHINA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 125. CHINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 126. CHINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 127. CHINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 128. CHINA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 129. INDIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 130. INDIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 131. INDIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 132. INDIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 133. INDIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 134. INDIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 135. INDIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 136. INDIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 143. INDONESIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 144. INDONESIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 145. JAPAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 146. JAPAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 147. JAPAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 148. JAPAN CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 149. JAPAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 150. JAPAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 151. JAPAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 152. JAPAN CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 159. MALAYSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 160. MALAYSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 167. PHILIPPINES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 168. PHILIPPINES CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 175. SINGAPORE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 176. SINGAPORE CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 183. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 184. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 191. TAIWAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 192. TAIWAN CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 193. THAILAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 194. THAILAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 195. THAILAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 196. THAILAND CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 197. THAILAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 198. THAILAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 199. THAILAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 200. THAILAND CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 207. VIETNAM CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 208. VIETNAM CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 219. DENMARK CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 220. DENMARK CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 221. DENMARK CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 222. DENMARK CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 223. DENMARK CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 224. DENMARK CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 225. DENMARK CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 226. DENMARK CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 227. EGYPT CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 228. EGYPT CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 229. EGYPT CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 230. EGYPT CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 231. EGYPT CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 232. EGYPT CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 233. EGYPT CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 234. EGYPT CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 235. FINLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 236. FINLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 237. FINLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 238. FINLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 239. FINLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 240. FINLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 241. FINLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 242. FINLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 243. FRANCE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 244. FRANCE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 245. FRANCE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 246. FRANCE CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 247. FRANCE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 248. FRANCE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 249. FRANCE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 250. FRANCE CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 251. GERMANY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 252. GERMANY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 253. GERMANY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 254. GERMANY CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 255. GERMANY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 256. GERMANY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 257. GERMANY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 258. GERMANY CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 265. ISRAEL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 266. ISRAEL CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 267. ITALY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 268. ITALY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 269. ITALY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 270. ITALY CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 271. ITALY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 272. ITALY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 273. ITALY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 274. ITALY CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 281. NETHERLANDS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 282. NETHERLANDS CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 289. NIGERIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 290. NIGERIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 291. NORWAY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 292. NORWAY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 293. NORWAY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 294. NORWAY CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 295. NORWAY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 296. NORWAY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 297. NORWAY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 298. NORWAY CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 299. POLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 300. POLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 301. POLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 302. POLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 303. POLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 304. POLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 305. POLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 306. POLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 307. QATAR CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 308. QATAR CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 309. QATAR CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 310. QATAR CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 311. QATAR CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 312. QATAR CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 313. QATAR CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 314. QATAR CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 315. RUSSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 316. RUSSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 317. RUSSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 318. RUSSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 319. RUSSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 320. RUSSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 321. RUSSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 322. RUSSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 324. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 326. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 328. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 330. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 332. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 334. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 336. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 338. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 339. SPAIN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 340. SPAIN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 341. SPAIN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 342. SPAIN CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 343. SPAIN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 344. SPAIN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 345. SPAIN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 346. SPAIN CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 347. SWEDEN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 348. SWEDEN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 349. SWEDEN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 350. SWEDEN CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 351. SWEDEN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 352. SWEDEN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 353. SWEDEN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 354. SWEDEN CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 355. SWITZERLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 356. SWITZERLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 357. SWITZERLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 358. SWITZERLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 359. SWITZERLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 360. SWITZERLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 361. SWITZERLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 362. SWITZERLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 363. TURKEY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 364. TURKEY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 365. TURKEY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 366. TURKEY CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 367. TURKEY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 368. TURKEY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 369. TURKEY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 370. TURKEY CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 371. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 372. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 373. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 374. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 375. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
TABLE 376. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
TABLE 377. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 378. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 379. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2023 (USD MILLION)
TABLE 380. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2024-2030 (USD MILLION)
TABLE 381. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
TABLE 382. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
TABLE 383. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018

Companies Mentioned

  • ACM Medical Laboratory, Inc.
  • Almac Group
  • Cerba HealthCare
  • CROMSOURCE by ClinChoice
  • Cryoport, Inc.
  • Eurofins Scientific SE
  • Exagen Inc.
  • Frontage Laboratories, Inc.
  • GBA Group
  • GCCL Co., Ltd.
  • ICON PLC
  • InterlabCorp
  • Intertek Group PLC
  • IQVIA Inc.
  • LabConnect, Inc.
  • Laboratory Corporation of America Holdings
  • Lambda Therapeutic Research Ltd.
  • Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
  • MDS Pharma Services
  • Medicover AB
  • Medpace, Inc.
  • MLM Medical Labs GmbH
  • Novotech Health Holdings
  • Pace Analytical Services, LLC
  • Precision Medicine Group, LLC
  • Quest Diagnostics Incorporated
  • REPROCELL Inc.
  • SGS S.A.
  • Shanghai Clinical Research Center
  • SMS Pharmaceuticals Ltd.
  • Sonic Healthcare International
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • Unilabs AB
  • Versiti, Inc.
  • WuXi AppTec

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.78 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned36

Related Topics

Related Reports

Global Central Lab Market Size, Share & Trends Analysis Report by Service (Genetic Services, Biomarker Services), End-use (Pharmaceutical Companies, Biotechnology Companies), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Central Lab Market Size, Share & Trends Analysis Report by Service (Genetic Services, Biomarker Services), End-use (Pharmaceutical Companies, Biotechnology Companies), Region, and Segment Forecasts, 2024-2030

  • Report
  • 200 Pages
  • Global
From
Central Lab Global Market Report 2024 - Product Image

Central Lab Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Global Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Forecast 2024-2030 - Product Image

Global Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, Storage & Retrieval, LIMS, ELN Software), Application (Drug Discovery, Diagnostics, Genomics & Proteomics), End User - Global Forecast to 2030 - Product Image

Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, Storage & Retrieval, LIMS, ELN Software), Application (Drug Discovery, Diagnostics, Genomics & Proteomics), End User - Global Forecast to 2030

  • Report
  • 247 Pages
  • Global
From

About the Central Lab Market

The Central Lab market within the context of Drug Discovery is a specialized segment of the pharmaceutical industry that provides services to support the development of new drugs. Central Labs provide a range of services, including sample collection, sample analysis, and data management. These services are essential for drug development, as they enable researchers to collect and analyze data from clinical trials and other studies. Central Labs also provide a range of other services, such as quality control, regulatory compliance, and data management. The Central Lab market is highly competitive, with a number of companies offering services to support drug discovery. Some of the major players in the market include Covance, PPD, Charles River Laboratories, and LabCorp. Other companies in the market include Quintiles, ICON, and Wuxi AppTec. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.